FindTrial
Sign In

The prospective study of 0.01% atropine eyedrops in the treatment of childhood myopia

The prospective study of sulfate atropine 0.5 mg + poly(ethylene glycol) 4 ml eyedrops in the treatment of childhood myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017154
Enrollment
Unknown
Registered
2018-07-13
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

A:sulfate atropine 0.5 mg + poly(ethylene glycol) 4 ml eyedrops combined with spectacles
B:spectacles

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: aged 6 to 14 years; spherical diopter=0.8; ability to finish the follow-up; assigned consent

Exclusion criteria

Exclusion criteria: other eye diseases except refractive error; allergy to atropine and tropicamide; history of using athma drugs during the past yeat; general diseases that may affect the use of atropine

Design outcomes

Primary

MeasureTime frame
diopter;axial length;corneal curvature;intraocular pressure;accommodation amplitude;accommodation flexibility;break up time;Schirmer;pupil size;—

Secondary

MeasureTime frame
best corrected visual acuity;near visual acuity;stereoacuity;—

Countries

China

Contacts

Public ContactXiaomei Qu

Eye & ENT Hospital of Fudan University

quxiaomei2002@126.com+86 13651803988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026